Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Purpose of this recall is to inform about changes to the adverse event labeling for medtronic spinal cord stimulation therapy. the issue is the potential for patients to experience spinal cord compression weeks to years after implant of spinal cord stimulation (scs) lead. spinal cord compression can lead to neurological deficit due to the formation of reactive fibrous tissue sometimes with an inflammatory component. the time to onset for spinal cord compression ranges from weeks to over 17 years and may progress after lead removal.
Model Catalog: 97740 (Lot serial: All Lots); Model Catalog: 37712 (Lot serial: All Lots); Model Catalog: 37744 (Lot serial: All Lots); Model Catalog: 37702 (Lot serial: All Lots); Model Catalog: 39565 (Lot serial: All Lots); Model Catalog: 7427 (Lot serial: All Lots); Model Catalog: 37704 (Lot serial: All Lots); Model Catalog: 37711 (Lot serial: All Lots); Model Catalog: 37703 (Lot serial: All Lots); Model Catalog: 3587A (Lot serial: All Lots); Model Catalog: 97714 (Lot serial: All Lots); Model Catalog: 3986A (Lot serial: All Lots); Model Catalog: 37714 (Lot serial: All Lots); Model Catalog: 977D260 (Lot serial: All Lots); Model Catalog: 977D160 (Lot serial: All Lots); Model Catalog: 977A160 (Lot serial: All Lots); Model Catalog: 977A275 (Lot serial: All Lots); Model Catalog: 977A260 (Lot serial: All Lots); Model Catalog: 977A190 (Lot serial: All Lots); Model Catalog: 977A175 (Lot serial: All Lots); Model Catalog: 977A290 (Lot serial: All Lots); Model Catalog: 7427V (Lot serial: All Lots); Model Catalog: 977
“If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.